APA (7th ed.) Citation

HP, G., PGM, d. B. E. S., IL, L., RO, S., F, T., M, P., . . . O, B. (2021). A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trial. American heart journal, 231, 128. https://doi.org/10.1016/j.ahj.2020.10.001

Chicago Style (17th ed.) Citation

HP, Guimarães, et al. "A Randomized Clinical Trial to Evaluate the Efficacy and Safety of Rivaroxaban in Patients with Bioprosthetic Mitral Valve and Atrial Fibrillation or Flutter: Rationale and Design of the RIVER Trial." American Heart Journal 231 (2021): 128. https://doi.org/10.1016/j.ahj.2020.10.001.

MLA (9th ed.) Citation

HP, Guimarães, et al. "A Randomized Clinical Trial to Evaluate the Efficacy and Safety of Rivaroxaban in Patients with Bioprosthetic Mitral Valve and Atrial Fibrillation or Flutter: Rationale and Design of the RIVER Trial." American Heart Journal, vol. 231, 2021, p. 128, https://doi.org/10.1016/j.ahj.2020.10.001.